Can exercise ease chemo nerve damage? new trial tests shorter programme
NCT ID NCT07307690
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares an 8-week versus a 12-week supervised exercise programme in 50 colorectal cancer patients receiving chemotherapy. The goal is to see if exercise can reduce chemotherapy-induced peripheral neuropathy—nerve damage causing tingling, numbness, and pain—and improve quality of life. Participants will do two 50-minute sessions per week with a physiotherapist, including strength and flexibility exercises.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- supervised physical exercise programme
- What this could lead to
- If it works, this could show that a shorter 8-week exercise programme is as effective as a 12-week one for reducing nerve pain and improving daily life.
- What could go wrong
- This is a small, early-stage trial with only 50 participants, so results may not apply to all patients. Exercise might not reduce nerve symptoms for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- Can a new drug shield nerves from Chemotherapy's side effects?
- A stitch in time: could a device make abdominal closure safer?
- Smartwatch could spot nerve damage before it starts
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk